University of Costa Rica, Centre for Research in Hematology and Related Disorders (CIHATA),Costa Rica.
Hamostaseologie. 2010 Nov;30 Suppl 1:S150-2.
Haemophilia A (HA) is X-chromosome linked bleeding disorders caused by deficiency of the coagulation factor VIII (FVIII). It is caused by FVIII gene intron 22 inversion (Inv22) in approximately 45% and by intron 1 inversion (Inv1) in 5% of the patients. Both inversions occur as a result of intrachromosomal recombination between homologous regions, in intron 1 or 22 and their extragenic copy located telomeric to the FVIII gene. The aim of this study was to analyze the presence of these mutations in 25 HA Costa Rican families.
PATIENTS, METHODS: We studied 34 HA patients and 110 unrelated obligate members and possible carriers for the presence of Inv22or Inv1. Standard analyses of the factor VIII gene were used incl. Southern blot and long-range polymerase chain reaction for inversion analysis.
We found altered Inv22 restriction profiles in 21 patients and 37 carriers. It was found type 1 and type 2 of the inversion of Inv22. During the screening for Inv1 among the HA patient, who were Inv22 negative, we did not found this mutation.
Our data highlight the importance of the analysis of Inv22 for their association with development of inhibitors in the HA patients and we are continuous searching of Inv1 mutation. This knowledge represents a step for genetic counseling and prevention of the inhibitor development.
血友病 A (HA) 是一种 X 染色体连锁的出血性疾病,由凝血因子 VIII (FVIII) 缺乏引起。它约有 45%由 FVIII 基因内含子 22 倒位 (Inv22) 引起,5%由内含子 1 倒位 (Inv1) 引起。这两种倒位都是由于同源区域(内含子 1 或 22 及其位于 FVIII 基因端粒侧的外显子拷贝之间的染色体内重组)之间的染色体内重组引起的。本研究的目的是分析 25 个哥斯达黎加血友病 A 家系中这些突变的存在情况。
患者、方法:我们研究了 34 名血友病 A 患者和 110 名无关的强制性成员和可能的携带者,以确定 Inv22 或 Inv1 的存在。标准的 FVIII 基因分析包括 Southern blot 和长距离聚合酶链反应用于反转录分析。
我们发现 21 名患者和 37 名携带者的 Inv22 限制图谱发生改变。发现了 Inv22 倒位的 1 型和 2 型。在对 Inv22 阴性的 HA 患者进行 Inv1 筛查时,未发现该突变。
我们的数据强调了分析 Inv22 对其与 HA 患者抑制剂发展的相关性的重要性,我们正在继续寻找 Inv1 突变。这些知识代表了遗传咨询和抑制剂发展预防的一个步骤。